Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

191
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
191
Relative Risk01:12

Relative Risk

476
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
476
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

335
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
335
Cancer Survival Analysis01:21

Cancer Survival Analysis

477
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
477
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

296
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
296
Actuarial Approach01:20

Actuarial Approach

146
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
146

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detergent-Containing Toothpaste Decreases Esophageal Mucosal Impedance and Alters Salivary Properties in Humans.

Allergy·2026
Same author

Human Papillomavirus Test Agreement Between Self-Collected Vaginal and Clinician-Collected Cervical Specimens.

Journal of lower genital tract disease·2026
Same author

Menopause symptoms and treatment in sexual minority women.

Menopause (New York, N.Y.)·2026
Same author

Evaluating the Relationship Between Electronic Health Record Workload and Advanced Practice Provider Work Status in Primary Care.

Journal of primary care & community health·2026
Same author

Considerations in Breast cancer screening, density and supplemental imaging in average-risk women.

Maturitas·2026
Same author

Treating Genitourinary Syndrome of Menopause in Postmenopausal Women with a History of Breast Cancer.

Drugs & aging·2026
Same journal

Sex Differences in Postoperative Delirium Severity and Burden in Older Adults.

Journal of women's health (2002)·2026
Same journal

Impact of the Availability of Women's Health Clinics on Unwanted Pregnancy Among Active Duty Service Women.

Journal of women's health (2002)·2026
Same journal

Advancing Women-Centered Product Development: Understanding the Health Needs of Women Roundtable Proceedings.

Journal of women's health (2002)·2026
Same journal

Moving Toward a Population Level Measure of Person-Centered Contraceptive Need in the United States.

Journal of women's health (2002)·2026
Same journal

The Interplay of Parental Leave, Career Achievement, and Burnout in Academic Neurologists: A Multicenter Study.

Journal of women's health (2002)·2026
Same journal

Vaginal Estrogen: Pearls for the Practitioner <i>A Practical Review of Evidence, Guidelines, and Prescribing Strategies for Genitourinary Syndrome of Menopause</i>.

Journal of women's health (2002)·2026
See all related articles

Related Experiment Video

Updated: Oct 6, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.4K

A Comparison of Perceived Lifetime Breast Cancer Risk to Calculated Lifetime Risk Using the Gail Risk Assessment

Jaya Mehta1, Kathy L MacLaughlin2, Denise M Millstine3

  • 1Department of General Internal Medicine, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA.

Journal of Women'S Health (2002)
|January 18, 2022
PubMed
Summary
This summary is machine-generated.

Many women underestimate their breast cancer risk, especially those with a family history or abnormal mammogram. Overall, more women overestimated their risk than underestimated it.

Keywords:
breast cancer riskbreast cancer screeningperceived breast cancer risk

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

408

Related Experiment Videos

Last Updated: Oct 6, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.4K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

408

Area of Science:

  • Oncology
  • Public Health
  • Medical Decision Making

Background:

  • Accurate perception of breast cancer risk is crucial for informed screening decisions.
  • Shared decision-making between patients and providers relies on understanding individual risk levels.

Purpose of the Study:

  • To compare women's perceived lifetime breast cancer risk with calculated risk using the Gail model.
  • To identify factors associated with underestimation or overestimation of breast cancer risk.

Main Methods:

  • Women presenting to Mayo Clinic completed a survey on perceived breast cancer risk.
  • Lifetime Gail risk scores were calculated and compared to perceived risk.
  • Statistical analysis identified factors associated with risk perception discrepancies.

Main Results:

  • A significant portion of women in elevated breast cancer risk categories underestimated their risk.
  • History of abnormal mammogram and family history of breast cancer were linked to risk underestimation.
  • Women in the sample overestimated their risk more frequently than they underestimated it.

Conclusions:

  • Underestimation of breast cancer risk is prevalent in certain patient groups.
  • Medical history factors like abnormal mammograms and family history are associated with underestimating risk.
  • Improving risk communication is essential for effective breast cancer screening strategies.